Prime Minister Ana Brnabic signed today with President of the Merck Sharp and Dohme pharmaceutical company (MSD) for Mid-Europe Cyril Schiever a Memorandum of Understanding, which is important for the future research centre BIO4 campus in Serbia.
Q:
A:
Memorandum on participation of MSD Pharmaceuticals in BIO4 campus signed
Belgrade,
10 May 2023
Brnabic expressed her gratitude to the MSD company for supporting our efforts to make Serbia a leader in biotechnology, biomedicine, bioresearch and bioinformatics.
She explained that the Memorandum of Understanding refers to MSD's participation in the BIO4 campus.
According to her, this is an extremely important reference that will help us to bring other large biopharmaceutical companies as well as research and development institutes to the BIO4 campus in the coming weeks and months, the construction of which will start by the end of the year, and to create a centre for future research in these areas for this part of Europe.
The Prime Minister added that it is our ambition to make it one of the most important centres in Europe, and assessed that this is an important date for the future BIO4 campus and for Serbia, as an important biotechnology research and development destination.
She recalled that the MSD company has been extremely active in Serbia since 1996 and cooperates with the Serbian Health Insurance Fund in order to provide the most modern and innovative therapies for the treatment of our patients, including the most difficult oncology patients.
Brnabic expressed her special gratitude for the company's social responsibility, stating that in the last few years, it has donated more than $66 million to Serbia, patients and the health system, of which $50 million is intended for innovative therapies.
Schiever explained that the agreement signed will allow MSD, which provides innovative care and treatment options for patients, to work on a research project within the BIO4 campus.
The BIO4 campus represents a very important project for Serbia and the region, and we expect it to be very important at the European level as well, he assessed and added that MSD wants to achieve a better understanding of how care is provided to patients, which implies the speed and efficiency of diagnostics.
We want to improve the efficiency of the health system. What is a challenge in today's time is effective care and that is what the BIO4 campus will contribute to, as a research centre, Schiever explained.
-
Belgrade, 20 June 2025Serbia, Egypt committed to strengthening trade, political ties
-
Belgrade/Cairo, 19 June 2025Gratitude to Egypt for support in evacuating Serbian citizens from Israel
-
Belgrade/Cairo, 19 June 2025Potential to enhance cooperation with Egypt in multiple fields
-
Belgrade/Cairo, 19 June 2025Serbia committed to preserving peace, understanding among religious communities
-
Belgrade/Cairo, 18 June 2025Serbia firmly committed to nurturing historical, spiritual ties with Egypt
-
Belgrade/Cairo, 18 June 2025Exceptionally substantial talks between Macut, Arab League Secretary-General
-
Belgrade/Cairo, 17 June 2025Considerable space for multifold increase in trade exchange with Egypt
-
Belgrade/Cairo, 17 June 2025Egypt is Serbia’s true ally, partner
-
Belgrade/Tirana, 16 June 2025Serbia fully supports further intensification of regional cooperation
-
Belgrade, 13 June 2025Erasure of Serbian identity in Kosovo and Metohija unacceptable to Serbia